dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
Advertisement

 

advertisement

 

Business Affairs Homepage

Johnson & Johnson to acquire Auris Health for $3.4 billion With possible $2.35 billion added if certain milestones are hit

Asheville Radiology Association joins Strategic Radiology The latest expansion by the imaging coalition brings 43 new physicians to the table

Maybe competition is good for what 'ails' hospitals Mergers may be good for business, but what about patients?

Frost & Sullivan outline 10 growth factors for precision imaging market Market predicted to be more than $8 billion by 2027

RadNet buys Kern Radiology The Bakersfield, California imaging group includes four offices

More of GE healthcare unit could be on block: CEO CEO Culp speaks in post-earnings call after company exceeds Q4 expectations

Philips, Lunit, Vuno in healthcare AI deal Forging partnerships to advance AI applications

Trade war forcing Philips to move production between US, China CEO van Houten addresses company growth in earnings call

Aetna, Anthem, Health Care Service, PNC Bank and IBM collaborate on healthcare blockchain 'ecosystem' Increasing industry transparency

Clinical wearables – remaining competitive in an evolving market Insights from Ravi Kuppuraj, Business Leader of Connected Sensing Venture for Philips

FDA warns duodenoscope makers about failure to comply with requirements

by Thomas Dworetzky , Contributing Reporter
The U.S. Food and Drug Administration issued warning letters on Friday to all three duodenoscope manufacturers after the trio failed to comply with postmarket reprocessing surveillance studies.

The follow-ups were legally required of U.S. duodenoscope manufacturers Olympus, Fujifilm and Pentax in 2015, after inadequate reprocessing of the devices led to bacterial contamination causing illness and patient deaths.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



When the agency ordered the plans, the makers responded positively. A spokeswoman for Fujifilm said at that time that it "will continue to work with the agency to ensure the best long-term sustainable practices.”

A spokesman from Olympus stated that the issue was being taken "extremely seriously, and we intend to comply and provide the requested information." And a Pentax Medical representative said it "intends to cooperate fully with FDA to meet this request."

The approved study plans called for the manufacturers “to conduct a study to sample and culture reprocessed duodenoscopes that are in clinical use, to learn more about issues that contribute to contamination, as well as a human factors study to assess how well trained hospital staff are following the reprocessing instructions,” the agency noted it its recent letters.

So far, says the government, Olympus “has failed to commence data collection, and Pentax and Fujifilm have failed to provide sufficient data.”

Olympus and Pentax also failed to meet the requirements for human factors studies to see how well hospital staff are following reprocessing instructions. Fujifilm met those requirements.

“The FDA has taken important steps to improve the reprocessing of duodenoscopes, and we’ve seen a reduction in reports of patient infections, but we need the required postmarket studies to determine whether these measures are being properly implemented in real world clinical settings and whether we need to take additional action to further improve the safety of these devices,” Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health said in the statement, adding that, “we expect these device manufacturers to meet their study obligations to ensure patient safety.”

In 2013, the agency discovered that there was a link between multi-drug-resistant bacteria and duodenoscopes – despite the fact that users were following the manufacturer-recommended cleaning procedures.
  Pages: 1 - 2 >>

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED